ENERZAIR BREEZHALER
ENERZAIR BREEZHALER
Approved
DIN Number
02501244
Drug Class
Human
Market Date
Nov 5, 2020
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02501244
AIG Number0362336001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AL12 INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE
Product Specifications
Dosage FormCapsule
Route of AdministrationInhalation
AHFS Classification12:12.08.12
Health Canada Classification
ACTIVE INGREDIENTS (3)
GLYCOPYRRONIUM (GLYCOPYRROLATE)Active
Strength: 50 MCG
Monograph: GLYCOPYRRONIUM (GLYCOPYRROLATE)
INDACATEROL (INDACATEROL ACETATE)Active
Strength: 150 MCG
Monograph: INDACATEROL (INDACATEROL ACETATE)
MOMETASONE FUROATEActive
Strength: 160 MCG
Monograph: MOMETASONE FUROATE